Home About Clinicians Patients Investors Careers Media Contact About A global leader in cancer treatment Sirtex Medical is a global healthcare business with offices in the US, Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver tumors called SIR-Spheres® Y-90 resin microspheres. Mission and Values Senior Leadership Team Who we are Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. What are SIR-Spheres® Y-90 resin microspheres? SIR-Spheres® Y-90 resin microspheres are a medical device used in Selective Internal Radiation Therapy (SIRT) for treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy. To view the Technical Bulletin regarding our indication, click here. Contact or follow us Contact Us SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. Terms of Use | Privacy Information W9-E-0214

Home About Clinicians Patients Investors Careers Media Contact Investors Sirtex Medical Limited (ASX:SRX) de-listed from the Australian Securities Exchange (ASX) on Monday, September 24th 2018. For all enquiries please contact Link Market Services, using the details below. Share Registry All share registry enquiries are to be directed to Link Market Services Limited Investors can visit the Sirtex Investor Centre at: https://investorcentre.linkmarketservices.com.au/Login.aspx/Login?issuer=SRX. You will need your Security Holder Reference Number (SRN) or your Holder Identification Number (HIN) and postcode when you log-in online. The Investor Centre provides a variety of important holding information and communication preferences. Alternatively, investors may contact Link Market Services as follows: Level 12, 680 George Street, Sydney, NSW 2000 Phone (Local): 1 300 554 474 Phone (International): +61 1 300 554 474 Facsimile: 02 9287 0303 Email: registrars@linkmarketservices.com.au Website: www.linkmarketservices.com.au Who we are Sirtex Medical is a global healthcare business with offices in the U.S., Australia, Germany and Singapore, working to improve outcomes in people with cancer. Our current lead product is a targeted radiation therapy for liver cancer called SIR-Spheres® Y-90 resin microspheres. What are SIR-Spheres® Y-90 resin microspheres? SIR-Spheres® Y-90 resin microspheres are a medical device used in Selective Internal Radiation Therapy (SIRT) for treatment of unresectable hepatocellular carcinoma (HCC) and unresectable metastatic liver tumors from primary colorectal cancer in patients refractory to or intolerant of chemotherapy. To view the Technical Bulletin regarding our indication, click here. Contact or follow us Contact Us SIR-Spheres® is a registered trademark of Sirtex SIR-Spheres Pty Ltd. Terms of Use | Privacy Information W9-E-0214